No insider purchases or sales are on record for Matinas BioPharma Holdings, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-09-06.
no insider purchases or sales on record
Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | — | — | $1.1M | $3.2M |
| OPERATING INCOME | $-7.0M | $-24.6M | $-23.8M | $-24.6M |
| NET INCOME | $-10.3M | $-24.3M | $-22.9M | $-21.0M |
| EPS (DILUTED) | -2.00 | -4.98 | -5.28 | -0.10 |
| OPERATING CASH FLOW | $-7.0M | $-15.9M | $-15.3M | $-19.2M |
| CASH | $4.0M | $7.3M | $4.8M | $6.8M |
No password to create and no card required. We store your email address and nothing else.